16
Jun
2026

Wuhan Wuyao Pharmaceutical Co., Ltd

Exhibitor at CPHI & PMEC China 2026 stand W2A28, Pharma Ingredients
About Us

Wuhan Wuyao Pharmaceutical Co Ltd, the subsidiary company of China Grand Enterprises and Grand Pharma (China) Co Ltd, is specialized in manufacturing and marketing of pharmaceutical raw materials. There are over 40 kinds of APIs manufactured under GMP standard. The manufacturing site has been inspected and approved by authorities from NMPA, USFDA and EDQM. Wuhan Wuyao Pharm is the leading manufacturer of API products like Metamizole Sodium, Metronidazole, Chloramphenicol, Adrenaline series and etc. Most of the products are with DMF and CEP certificates.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
Distributor/Import Export
Manufacturer/Innovator
Primary activities
API Producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W2A28, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • Ethambutol Hydrohloride

    Product Ethambutol Hydrohloride

    White or almost white, crystalline powder, hygroscopic. Freely soluble in water, soluble in ethanol (96 per cent).It belongs to antituberculosis drug.
  • Bicalutamide

    Product Bicalutamide

    Oncology API
  • Chloramphenicol

    Product Chloramphenicol

    A White or almost white, crystalline poeder, practically insoluble in water, freely soluble in acetone and in alcohol. It is considered a prototypical broad-spectrum antibiotic.
  • Cytarabine

    Product Cytarabine

    Oncology API
  • Enoxacin

    Product Enoxacin

    white to pale yellow-brown crystals or crystalline powder.